IQV

NYSE

IQVIA HOLDINGS INC.

Health Care, Life Sciences Tools & Services

$238.70

close 7 Aug 2026

+32.54%

52-week change

$39.84B

market cap

$154.50

$251.36

52-week range

Valuation

Market cap$39.84B

P/E (TTM / 5y avg)29.65x34.65x

Forward P/E (FY2026 / FY2027)18.41x16.53x

PEG (TTM / fwd)2.681.61

P/S (TTM)2.40x

P/B6.40x

EV/EBITDA (TTM)15.96x

FCF yield (TTM)5.31%

Cash flow & dividend

FCF (TTM)$2.12B

FCF per share (TTM)$12.68

FCF margin (TTM)12.72%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+8.41%

Diluted EPS YoY, latest Q+15.00%

Operating margin (TTM)13.23%

Net margin (TTM)8.33%

ROE (latest FY)20.91%

Net debt / EBITDA (TTM)4.12

Interest coverage (TTM)2.91

Price

-3.80%-0.78%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +7.50%10Y CAGR +11.01%

Diluted EPS

5Y CAGR +40.54%10Y CAGR +9.79%

FCF per share

5Y CAGR +11.43%10Y CAGR +14.08%

Operating cash flow

5Y CAGR +6.26%10Y CAGR +18.75%

Free cash flow

5Y CAGR +8.84%10Y CAGR +17.82%

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -2.37%10Y CAGR +3.57%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date26 Oct 2026bmo

EPS estimate$3.29

Revenue estimate$4.40B

Last reported

Date—

EPS——

Revenue——